Located at 1900 2nd Avenue 2m32 Psychiatric Pavilion in New York, New York, NYC HHC Metropolitan Hospital Center – Methadone Treatment Program is a government-operated addiction treatment provider. The Methadone Treatment Program program is operated by NYC HHC Metropolitan Hospital Center.
Its services include medication-assisted treatment (MAT), a federally certified opioid treatment program, co-occurring (dual diagnosis) mental health treatment, and telehealth therapy. Clinicians use approaches such as motivational interviewing, relapse prevention, and substance use disorder counseling. For opioid use disorder, the program uses methadone and naltrexone.
Payment options include government funding for substance use treatment, Medicare, Medicaid, private health insurance, cash or self-payment, and state-financed health insurance plan other than Medicaid. A sliding fee scale based on income is available. Coverage depends on your specific plan, so verify benefits before admission.
The program accepts young adults, adults, and seniors. It offers specialized groups for adolescents, young adults, pregnant/postpartum women, and seniors or older adults. Sign language services are available for deaf and hard-of-hearing clients.
NYC HHC Metropolitan Hospital Center – Methadone Treatment Program is accredited by The Joint Commission and licensed or certified by the state substance use treatment agency, SAMHSA certification for opioid treatment program (OTP), and drug Enforcement Agency (DEA).
Support services include aftercare/continuing care, discharge planning, naloxone and overdose education, and assistance with obtaining social services.